Cargando…

Expression of endoglin (CD105) in cervical cancer

In this study, we have investigated the role of endoglin (CD105), a regulator of transforming growth factor (TGF)-β(1) signalling on endothelial cells, basic fibroblast growth factor (bFGF) and vascular endothelial growth factor-A (VEGF-A) in cervical cancer. We have measured the number and determin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zijlmans, H J, Fleuren, G J, Hazelbag, S, Sier, C F, Dreef, E J, Kenter, G G, Gorter, A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696762/ https://www.ncbi.nlm.nih.gov/pubmed/19352388 http://dx.doi.org/10.1038/sj.bjc.6605009

Ejemplares similares

Role of IL-12p40 in cervical carcinoma
por: Zijlmans, H J M A A, et al.
Publicado: (2012)

CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients
por: Schrevel, M, et al.
Publicado: (2012)

The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer
por: Beresford, M J, et al.
Publicado: (2006)

Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma
por: Saroufim, A, et al.
Publicado: (2014)

Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review
por: Sier, Vincent Q., et al.
Publicado: (2021)

Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
por: Di Paolo, Virginia, et al.
Publicado: (2018)

Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer
por: Nedergaard, B S, et al.
Publicado: (2007)

Increased expression of pAKT is associated with radiation resistance in cervical cancer
por: Kim, T-J, et al.
Publicado: (2006)

CD105 (Endoglin) as negative prognostic factor in AML
por: Kauer, Joseph, et al.
Publicado: (2019)

Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study
por: Samuels, Sanne, et al.
Publicado: (2016)

Study of expression of endoglin (CD105) in oral squamous cell carcinoma
por: Mahapatra, Niva, et al.
Publicado: (2021)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer
por: Goossens-Beumer, I J, et al.
Publicado: (2014)

Identification of CD105 (endoglin) as novel risk marker in CLL
por: Greiner, Sarah M., et al.
Publicado: (2022)

The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer
por: Al-Saad, S, et al.
Publicado: (2008)

Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status
por: Bock, Annika J., et al.
Publicado: (2011)

Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer
por: Kubben, F J G M, et al.
Publicado: (2006)

Expression of IP-10 related to angiogenesis in uterine cervical cancers
por: Sato, E, et al.
Publicado: (2007)

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer
por: Kubben, F J G M, et al.
Publicado: (2006)

PROGNOSTIC ROLE OF CD44 EXPRESSION AND NEOVASCULARIZATION DETERMINED BY ENDOGLIN (CD105) IN GLIOBLASTOMA PATIENTS
por: Mihić, Josip, et al.
Publicado: (2019)

Tumour-associated CD66b(+) neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer
por: Carus, A, et al.
Publicado: (2013)

Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer
por: Nogués, Ana, et al.
Publicado: (2020)

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women
por: Luttmer, Roosmarijn, et al.
Publicado: (2016)

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
por: Kahlert, C, et al.
Publicado: (2009)

Molecular profiling of cervical cancer progression
por: Hagemann, T, et al.
Publicado: (2007)

Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival
por: Pitkin, L, et al.
Publicado: (2007)

CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding
por: Adam, P J, et al.
Publicado: (2006)

Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma
por: Yu, Decai, et al.
Publicado: (2007)

ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumours
por: Gromova, Petra, et al.
Publicado: (2012)

CD133 expression is an independent prognostic marker for low survival in colorectal cancer
por: Horst, D, et al.
Publicado: (2008)

Tissue level, activation and cellular localisation of TGF-β1 and association with survival in gastric cancer patients
por: Hawinkels, L J A C, et al.
Publicado: (2007)

Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers
por: Surowiak, P, et al.
Publicado: (2006)

Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer
por: Schaefer, C, et al.
Publicado: (2005)

Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
por: Hao, J, et al.
Publicado: (2010)

Endoglin (CD105) and proliferation index in recurrent glioblastoma treated with anti-angiogenic therapy
por: Bastos, António G. P., et al.
Publicado: (2022)

High-risk HPV type-specific clearance rates in cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2007)

Detection of adeno-associated virus type 2 genome in cervical carcinoma
por: Zheng, B Y, et al.
Publicado: (2006)

Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases
por: Gök, M, et al.
Publicado: (2011)

CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence
por: Hirata, K, et al.
Publicado: (2013)

The effect of surgically induced ischaemia on gene expression in a colorectal cancer xenograft model
por: Atkin, G, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_i0vjknlq74k3sbaafl4leelem9